You have 9 free searches left this month | for more free features.

City

Condition

Non-Small-Cell Lung Cancer (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Jiangsu HengRui Medicine Co., Ltd. (1)

Collaborator

Intervention

shr-1701 (1)

shr-1701,famitinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

shr-1701，famitinib

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Non-Small-Cell Lung Cancer Trial (SHR-1701,Famitinib, SHR-1701)

Not yet recruiting

Non-Small-Cell Lung Cancer

SHR-1701，Famitinib
SHR-1701

(no location specified)

Jan 5, 2021